{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:03:44Z","timestamp":1774976624068,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006708","name":"Appalachian Regional Commission","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100006708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006708","name":"Appalachian Regional Commission","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100006708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006708","name":"Appalachian Regional Commission","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100006708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006708","name":"Appalachian Regional Commission","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100006708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006708","name":"Appalachian Regional Commission","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100006708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006708","name":"Appalachian Regional Commission","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100006708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006708","name":"Appalachian Regional Commission","doi-asserted-by":"publisher","award":["UH3DA044830"],"award-info":[{"award-number":["UH3DA044830"]}],"id":[{"id":"10.13039\/100006708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-026-01421-1","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:35:31Z","timestamp":1772015731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Convenience, rapport and skill: effective rural hepatitis C treatment, qualitative findings from a mobile harm reduction-informed tele-medicine intervention in Northern New England, 2022\u20132024"],"prefix":"10.1186","volume":"23","author":[{"given":"K.","family":"Nolte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Del Toro-Mejias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bianchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tarplin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hoskinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. D.","family":"Friedmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. J.","family":"Stopka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"6","key":"1421_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S2468-1253(23)00018-3","volume":"8","author":"A Artenie","year":"2023","unstructured":"Artenie A, Stone J, Fraser H, Stewart D, Arum C, Lim AG, et al. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):533\u201352.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1421_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12954-023-00916-5","volume":"21","author":"E Romo","year":"2024","unstructured":"Romo E, Stopka TJ, Jesdale BM, Wang B, Mazor KM, Friedmann PD. Association of Spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States. Harm Reduct J. 2024;21(1):23.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1421_CR3","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/QAI.0000000000001098","volume":"73","author":"MM Van Handel","year":"2016","unstructured":"Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, et al. County-Level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject Drugs, United States. JAIDS J Acquir Immune Defic Syndr. 2016;73(3):323\u201331.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"1421_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12954-021-00505-4","volume":"18","author":"SJ Shayan","year":"2021","unstructured":"Shayan SJ, Nazari R, Kiwanuka F. Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis. Harm Reduct J. 2021;18(1):59.","journal-title":"Harm Reduct J"},{"issue":"10","key":"1421_CR5","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/cid\/ciu643","volume":"59","author":"AG Suryaprasad","year":"2014","unstructured":"Suryaprasad AG, White JZ, Xu F, Eichler BA, Hamilton J, Patel A, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the united States, 2006\u20132012. Clin Infect Dis. 2014;59(10):1411\u20139.","journal-title":"Clin Infect Dis"},{"issue":"13","key":"1421_CR6","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1080\/10826084.2021.1958863","volume":"56","author":"NA Carnes","year":"2021","unstructured":"Carnes NA, Asher AK, Bohm MK, Bessler PA. Access to HIV, viral Hepatitis, and substance use disorder treatment\/overdose prevention services: a qualitative analysis of syringe service programs (SSPs) serving rural PWID. Subst Use Misuse. 2021;56(13):1933\u201340.","journal-title":"Subst Use Misuse"},{"issue":"6","key":"1421_CR7","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1177\/00333549221143086","volume":"138","author":"MD Carmody","year":"2023","unstructured":"Carmody MD, Wagner K, Bizstray B, Thornton K, Fiuty P, Rosario AD, et al. Cascade of care for hepatitis C virus infection among young adults who inject drugs in a rural County in New Mexico. Public Health Rep. 2023;138(6):936\u201343.","journal-title":"Public Health Rep"},{"key":"1421_CR8","doi-asserted-by":"publisher","first-page":"103930","DOI":"10.1016\/j.drugpo.2022.103930","volume":"112","author":"SM Walters","year":"2023","unstructured":"Walters SM, Frank D, Felsher M, Jaiswal J, Fletcher S, Bennett AS, et al. How the rural risk environment underpins hepatitis C risk: qualitative findings from rural Southern Illinois, United States. Int J Drug Policy. 2023;112:103930.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1421_CR9","doi-asserted-by":"publisher","first-page":"e2555125","DOI":"10.1001\/jamanetworkopen.2025.55125","volume":"9","author":"PD Friedmann","year":"2026","unstructured":"Friedmann PD, Wilson D, de Gijsel D, Nolte K, Dejace J, Hoskinson R, et al. Mobile telemedicine for treating chronic hepatitis C among rural people who inject drugs: a randomized clinical trial. JAMA Netw Open. 2026;9(1):e2555125.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"1421_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/07853890.2023.2182908","volume":"55","author":"E Suarez","year":"2023","unstructured":"Suarez E, Bartholomew TS, Plesons M, Ciraldo K, Ostrer L, Serota DP, et al. Adaptation of the Tele-Harm reduction intervention to promote initiation and retention in buprenorphine treatment among people who inject drugs: a retrospective cohort study. Ann Med. 2023;55(1):733\u201343.","journal-title":"Ann Med"},{"issue":"8","key":"1421_CR11","doi-asserted-by":"publisher","first-page":"e2118487","DOI":"10.1001\/jamanetworkopen.2021.18487","volume":"4","author":"E Weintraub","year":"2021","unstructured":"Weintraub E, Seneviratne C, Anane J, Coble K, Magidson J, Kattakuzhy S, et al. Mobile telemedicine for buprenorphine treatment in rural populations with opioid use disorder. JAMA Netw Open. 2021;4(8):e2118487.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1421_CR12","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1016\/j.amepre.2021.05.044","volume":"61","author":"D Broz","year":"2021","unstructured":"Broz D, Carnes N, Chapin-Bardales J, Des Jarlais DC, Handanagic S, Jones CM, et al. Syringe services programs\u2019 role in ending the HIV epidemic in the U.S.: why we cannot do it without them. Am J Prev Med. 2021;61(5):S118\u201329.","journal-title":"Am J Prev Med"},{"issue":"1","key":"1421_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12954-023-00775-0","volume":"20","author":"T Austin","year":"2023","unstructured":"Austin T, Lavalley J, Parusel S, Collins AB, Olding M, Boyd J. Women who use drugs: engagement in practices of harm reduction care. Harm Reduct J. 2023;20(1):49.","journal-title":"Harm Reduct J"},{"key":"1421_CR14","doi-asserted-by":"crossref","unstructured":"Englander H, Thakrar AP, Bagley SM, Rolley T, Dong K, Hyshka E. Caring for hospitalized adults with opioid use disorder in the era of fentanyl: a review. JAMA Intern Med. 2024;184(6):691.","DOI":"10.1001\/jamainternmed.2023.7282"},{"issue":"1","key":"1421_CR15","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/add.16320","volume":"119","author":"L Lalanne","year":"2024","unstructured":"Lalanne L, Roux P, Donadille C, Briand Madrid L, C\u00e9lerier I, Chauvin C, et al. Drug consumption rooms are effective to reduce at-risk practices associated with HIV\/HCV infections among people who inject drugs: results from the COSINUS cohort study. Addiction. 2024;119(1):180\u201399.","journal-title":"Addiction"},{"issue":"1","key":"1421_CR16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12954-017-0196-4","volume":"14","author":"M Hawk","year":"2017","unstructured":"Hawk M, Coulter RWS, Egan JE, Fisk S, Reuel Friedman M, Tula M, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017;14(1):70.","journal-title":"Harm Reduct J"},{"key":"1421_CR17","unstructured":"Substance Abuse and Mental Health Services Administration. Harm reduction framework. Rockville, MD: Center for Substance Abuse Prevention, Substance Abuse and Mental Health Services Administration; 2023."},{"key":"1421_CR18","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V. Thematic analysis. In: APA Handbook of Resarch Methods in Psychology. 2012. pp. 57\u201371.","DOI":"10.1037\/13620-004"},{"issue":"3","key":"1421_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/jnu.12863","volume":"55","author":"O Heidari","year":"2023","unstructured":"Heidari O, Tormohlen K, Dangerfield DT, Tobin KE, Farley JE, Aronowitz SV. Barriers and facilitators to primary care engagement for people who inject drugs: a systematic review. J Nurs Scholarsh. 2023;55(3):605\u201322.","journal-title":"J Nurs Scholarsh"},{"issue":"5","key":"1421_CR20","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1097\/MCG.0000000000000151","volume":"49","author":"DM Evon","year":"2015","unstructured":"Evon DM, Golin CE, Bonner JE, Grodensky C, Velloza J. Adherence during antiviral treatment regimens for chronic hepatitis C: a qualitative study of Patient-reported facilitators and barriers. J Clin Gastroenterol. 2015;49(5):e41\u201350.","journal-title":"J Clin Gastroenterol"},{"key":"1421_CR21","doi-asserted-by":"publisher","first-page":"209453","DOI":"10.1016\/j.josat.2024.209453","volume":"165","author":"RJ Fredericksen","year":"2024","unstructured":"Fredericksen RJ, Mixson LS, Estadt AT, Leichtling G, Bresett J, Zule W, et al. Barriers to retention in inpatient and residential drug treatment among persons who use opioids and\/or injection drugs living in the rural U.S. J Subst Use Addict Treat. 2024;165:209453.","journal-title":"J Subst Use Addict Treat"},{"key":"1421_CR22","doi-asserted-by":"publisher","first-page":"116660","DOI":"10.1016\/j.socscimed.2024.116660","volume":"346","author":"TJ Stopka","year":"2024","unstructured":"Stopka TJ, Estadt AT, Leichtling G, Schleicher JC, Mixson LS, Bresett J, et al. Barriers to opioid use disorder treatment among people who use drugs in the rural United States: A qualitative, multi-site study. Soc Sci Med. 2024;346:116660.","journal-title":"Soc Sci Med"},{"issue":"1","key":"1421_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/eurpub\/ckad008","volume":"33","author":"A Uusk\u00fcla","year":"2023","unstructured":"Uusk\u00fcla A, Feelemyer J, Des Jarlais DC. HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: a scoping review. Eur J Public Health. 2023;33(3):381\u20138.","journal-title":"Eur J Public Health"},{"issue":"3","key":"1421_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11904-018-0393-0","volume":"15","author":"AJ Schranz","year":"2018","unstructured":"Schranz AJ, Barrett J, Hurt CB, Malvestutto C, Miller WC. Challenges facing a rural opioid epidemic: treatment and prevention of HIV and hepatitis C. Curr HIV\/AIDS Rep. 2018;15(3):245\u201354.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"1421_CR25","unstructured":"National Harm Reduction Coalition. Principles of Harm Reduction [Internet]. 2024 [cited 2025 May 5]. Available from: https:\/\/harmreduction.org\/about-us\/principles-of-harm-reduction\/"},{"issue":"4","key":"1421_CR26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3122\/jabfm.2022.220427R1","volume":"36","author":"A Stewart","year":"2023","unstructured":"Stewart A, Craig-Neil A, Hodwitz K, Wang R, Cheng D, Arbess G, et al. Increasing treatment rates for hepatitis C in primary care. J Am Board Fam Med. 2023;36(4):591\u2013602.","journal-title":"J Am Board Fam Med"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-026-01421-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01421-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-026-01421-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:58:50Z","timestamp":1774972730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-026-01421-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1421"],"URL":"https:\/\/doi.org\/10.1186\/s12954-026-01421-1","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}